+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

From
From
From
From
From
Hunter Syndrome - Epidemiology Forecast to 2032 - Product Thumbnail Image

Hunter Syndrome - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Chronic Inducible Urticaria Epidemiology Forecast to 2032 - Product Thumbnail Image

Chronic Inducible Urticaria Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Adult-onset Still's Disease - Epidemiology Forecast to 2032 - Product Thumbnail Image

Adult-onset Still's Disease - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Hypoparathyroidism - Epidemiology Forecast to 2032 - Product Thumbnail Image

Hypoparathyroidism - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
Gender dysphoria - Epidemiology Insight - 2032 - Product Thumbnail Image

Gender dysphoria - Epidemiology Insight - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
From
From
Duchenne Muscular Dystrophy - Epidemiology Forecast to 2032 - Product Thumbnail Image

Duchenne Muscular Dystrophy - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more